Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FM49K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $91,944
Award facts
- Contract value 100% obligated
- $91,943.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 29, 2026, the Defense Logistics Agency awarded a delivery order valued at $91,943.50 to AmerSourceBergen Drug Corp for the supply of RINVOQ ER 45 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 30, 2026. The contract will be performed at AmerSourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerSourceBergen), a major pharmaceutical distributor serving federal government healthcare systems.
This delivery order is issued under AmerSourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including products across multiple therapeutic domains. RINVOQ ER (upadacitinib extended-release) is a selective Janus kinase inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the diverse therapeutic portfolio that AmerSourceBergen delivers through its federal contracts to support military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FM49K?
SPE2DR26FM49K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FM49K worth?
The government has obligated $91,944 on SPE2DR26FM49K.
Is contract SPE2DR26FM49K an order under another contract?
Yes. SPE2DR26FM49K is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM49K competed?
The extent of competition for SPE2DR26FM49K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award